Burn dressing

By designing burn dressings containing boric acid hydrogel and chitosan film, the problem that burn dressings in the prior art cannot have multiple functions is solved, and the slow delivery of antibacterial agents and wound healing is achieved, which significantly improves the burn dressings' Preventive and therapeutic effects.

CN116271180BActive Publication Date: 2024-11-01BEIJING KANGYUJIAN MEDICAL DEVICES CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310291217.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-23
Publication Date
2024-11-01
Estimated Expiration
2043-03-23

AI Technical Summary

Technical Problem

Existing burn dressings cannot have good antibacterial properties, fluid absorption, analgesic, hemostasis and healing properties, resulting in the risk of antibacterial drug abuse and infection, and cannot effectively prevent and treat burn wound infection.

Method used

A burn dressing is designed, including a backing layer, an absorbing layer, a drug release layer and a drug delivery layer. The drug release layer is a semi-solid substance with a viscosity of 50,000-70,000mpa.s, containing antibacterial agents, such as aminoglycoside antibiotics, through The swelling effect of boric acid hydrogel and glucose molecules slowly releases antibacterial agents, combining the healing and analgesic effects of chitosan film to achieve slow delivery of antibacterial agents.

Benefits of technology

The slow delivery of antibacterial agents is achieved, effectively preventing and treating infections of burn wounds, promoting wound healing, reducing scar formation, and improving the safety and effectiveness of dressings.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116271180B_ABST
    Figure CN116271180B_ABST
Patent Text Reader

Abstract

The present invention provides a burn dressing, comprising: a backing layer; an absorption layer located below the backing layer; a drug release layer located below the absorption layer, wherein the detection limit of the drug release layer for glucose molecules is a preset value; a drug delivery layer located below the drug release layer; and a peeling layer located below the drug delivery layer. The solution of the present invention can achieve the slow delivery of antibacterial agents to the burn wound surface, thereby effectively preventing and treating the infection of the burn wound surface.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of dressings, in particular to a burn dressing. Background Art

[0002] Accidental factors such as high temperature, electric current, and chemicals can cause skin burns, which can damage the integrity of the original skin structure and the immune barrier. Shock, infection, and multiple organ failure are the three major complications of burn wounds, among which infection has the highest mortality rate. Bacteria can penetrate deep into the burn site and even expand the scope of infection. Infection of large areas of burn wounds can even cause sepsis, pus, and imbalance of bacterial microecology, posing a major threat to the patient's life, health, and quality of life.

[0003] Traditional treatments for burn infection can be roughly divided into surgical treatment and non-surgical treatment. Surgical treatment mainly involves debridement of the wound with autologous skin or allogeneic skin, combined with antibiotics to solve the infection problem; non-surgical treatment mainly involves covering the wound with wound dressings, such as nano-silver ion dressings, chitosan dressings, topical antibacterial drugs (antibiotics, natural antibacterial drugs, etc.), and negative pressure closed drainage technology. Due to the slow healing time of burn infection wounds, the use of antibiotics alone will result in less than ideal drug release time and speed, greatly reducing the effect of preventing wound infection. In addition, factors such as drug resistance caused by the abuse of antibiotics, scar tissue formed after poor healing, limited sources of autologous skin transplants, and immunogenicity of allogeneic skin mean that the quality of treatment still needs to be improved. Wound dressings such as nano silver ion dressings have been used as local antibacterial drugs for burn wounds for more than 50 years. However, nano silver ion dressings cannot promote wound healing, and there are safety risks for other alternative antibacterial dressings. Chitosan dressings have antibacterial, hemostatic, healing and analgesic functions, and can promote the division of multiple functional cells such as epithelial cells and fibroblasts and the growth of extracellular matrix, significantly accelerate wound healing, and reduce scar formation. However, chitosan hydrogel film dressings have poor liquid absorption performance, resulting in poor healing effect. At the same time, relying solely on the antibacterial properties of chitosan hydrogel film, the wound is still at risk of infection.

[0004] It can be seen that the dressings in the prior art have only partial and single functions and cannot have good antibacterial properties, liquid absorption, analgesia, hemostasis, and healing properties, which leads to the abuse of antibacterial drugs and cannot meet the needs of patients. Summary of the invention

[0005] The technical problem to be solved by the present invention is to provide a burn dressing that can slowly deliver an antibacterial agent to a burn wound, thereby effectively preventing and treating infection of the burn wound.

[0006] In order to solve the above technical problems, the technical solution of the present invention is as follows:

[0007] A burn dressing comprising:

[0008] Backing layer;

[0009] an absorbent layer disposed beneath the backing layer;

[0010] A drug-releasing layer located below the absorption layer, wherein the detection limit of the drug-releasing layer for glucose molecules is a preset value;

[0011] a drug delivery layer located below the drug release layer; and

[0012] A release layer is located below the drug delivery layer.

[0013] Optionally, the drug-releasing layer is a semisolid material with a viscosity of 50,000-70,000 mPa.s.

[0014] Optionally, the drug-releasing layer is boric acid hydrogel.

[0015] Optionally, the drug-releasing layer contains an antibacterial agent.

[0016] Optionally, the antibacterial agent is an aminoglycoside antibiotic.

[0017] Optionally, the drug delivery layer is a chitosan film.

[0018] Optionally, the drug delivery layer is provided with holes with a pore size of 0.01 to 0.1 mm.

[0019] Optionally, the drug delivery layer has a thickness of 0.04 to 0.1 mm.

[0020] Optionally, the absorption layer is sponge, non-woven fabric or medical gauze.

[0021] Optionally, the preset value is 1 mg / L.

[0022] The above solution of the present invention includes at least the following beneficial effects:

[0023] The above solution of the present invention comprises a backing layer; an absorption layer below the backing layer; a drug release layer below the absorption layer, wherein the detection limit of the drug release layer for glucose molecules is a preset value; a drug delivery layer below the drug release layer; and a peeling layer below the drug delivery layer. In this way, the antibacterial agent can be slowly delivered to the burn wound surface, thereby effectively preventing and treating infection of the burn wound surface. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 is a schematic structural diagram of a burn dressing provided by an embodiment of the present invention;

[0025] Figure 2It is a schematic diagram of the slow delivery of the antibacterial agent after the drug-releasing layer 3 provided in an embodiment of the present invention swells with glucose molecules. DETAILED DESCRIPTION

[0026] The exemplary embodiments of the present disclosure will be described in more detail below with reference to the accompanying drawings. Although exemplary embodiments of the present invention are shown in the accompanying drawings, it should be understood that the present invention can be implemented in various forms and should not be limited by the embodiments set forth herein. On the contrary, these embodiments are provided to enable a more thorough understanding of the present invention and to fully convey the scope of the present invention to those skilled in the art.

[0027] like Figure 1 As shown, an embodiment of the present invention provides a burn dressing, comprising:

[0028] A backing layer 1; an absorption layer 2 located below the backing layer 1; a drug release layer 3 located below the absorption layer 2, wherein the detection limit of the drug release layer 3 for glucose molecules is a preset value; a drug delivery layer 4 located below the drug release layer 3; and a peeling layer 5 located below the drug delivery layer 4. Here, the peeling layer 5 may be a release paper, which can protect the burn dressing, ensure the viscosity of the burn dressing, and enable the burn dressing to be firmly attached to the patient's skin.

[0029] In this embodiment of the present invention, by stacking the backing layer 1, the absorption layer 2, the drug release layer 3, the drug delivery layer 4 and the peeling layer 5 in sequence, the antibacterial agent can be slowly delivered to the burn wound, thereby effectively preventing and treating the infection of the burn wound.

[0030] It should be noted that the application scope of this dressing is not limited to burn wounds, but is also suitable for the care and isolation protection of chronic wounds, traumatic wounds, surgical wounds, etc., to inhibit bacteria, protect wounds and promote wound healing.

[0031] In an optional embodiment of the present invention, the drug-releasing layer 3 is a semi-solid material with a viscosity of 50,000-70,000 mPa.s (viscosity unit: millipascal.second).

[0032] In this embodiment, the viscosity of the semi-solid drug release layer 3 is 50000-70000 mPa.s, which can ensure that the drug release layer 3 is closely attached to the absorption layer 2 and the drug delivery layer 4, so that the drug release layer 3, the absorption layer 2 and the drug delivery layer 4 can fully play their roles.

[0033] In another optional embodiment of the present invention, the drug-releasing layer 3 is boric acid hydrogel.

[0034] In this embodiment, the boric acid hydrogel has an excellent detection limit and can respond to the glucose molecules in the wound exudate, thereby causing swelling, thereby achieving the purpose of slowly delivering the antibacterial drug to the patient's burn wound, thereby making the release time and speed of the antibacterial agent reach an ideal state.

[0035] It should be noted that the boric acid hydrogel can be prepared by free radical polymerization initiated by light from monomers including 3-acrylamidophenylboronic acid, acrylamide, N,N-methylenebisacrylamide and a photoinitiator.

[0036] In another optional embodiment of the present invention, the drug-releasing layer 3 contains an antibacterial agent.

[0037] In this embodiment, the antibacterial agent can be released from the drug release layer 3 after swelling due to the reaction of the drug release layer 3 with glucose molecules in the wound exudate, and slowly delivered to the burn wound through the drug delivery layer 4 to promote wound healing.

[0038] It should be noted that the antibacterial agent is dispersed in the prepolymer solution of the boric acid hydrogel and is fixed in the hydrogel matrix through photo-initiated free radical polymerization.

[0039] In another optional embodiment of the present invention, the antibacterial agent is an aminoglycoside antibiotic.

[0040] In this embodiment, specifically, the antibacterial agent may include but is not limited to: gentamicin sulfate; gentamicin sulfate has a broad-spectrum antibiotic effect on Gram-positive bacteria and Gram-negative bacteria, and can be used for antibacterial treatment of burn wounds to prevent wound infections.

[0041] In another optional embodiment of the present invention, the drug delivery layer 4 is a chitosan film.

[0042] In this embodiment, the chitosan membrane has analgesic, hemostatic and healing properties, which can accelerate the healing of the wound. The chitosan membrane has lotion properties, which can achieve the drainage of wound exudate, so that the drug delivery layer 4 drains the wound exudate to the drug release layer 3 to take effect, causing the drug release layer 3 to swell and release the antibacterial agent, so that the antibacterial agent is slowly delivered to the wound through the drug delivery layer 4, thereby promoting wound healing.

[0043] It should be noted that the chitosan film may be composed of a mixture of chitosan and glycerol.

[0044] In another optional embodiment of the present invention, the drug delivery layer 4 is provided with holes with a pore size of 0.01 to 0.1 mm.

[0045] In this embodiment, the wound exudate can pass through the holes in the drug delivery layer 4, react with the drug release layer 3 and swell to release the antibacterial agent, and can also deliver the antibacterial agent to the burn wound, thereby effectively preventing and treating wound infection.

[0046] In another optional embodiment of the present invention, the thickness of the drug delivery layer 4 is 0.04-0.1 mm.

[0047] In this embodiment, when the drug-releasing layer 3 releases the antibacterial agent, the antibacterial agent needs to be gradually delivered to the burn wound layer by layer through the drug delivery layer 4. The thickness of the drug delivery layer 4 is set to 0.04-0.1 mm, which can meet the requirement of slowly delivering the antibacterial agent to the burn wound.

[0048] In another optional embodiment of the present invention, the absorption layer 2 is sponge, non-woven fabric or medical gauze.

[0049] In this embodiment, the core of the absorption layer 2 may include but is not limited to: sponge, non-woven fabric or medical gauze; the absorption layer 2 can absorb the exudate from the patient's burn wound, thereby ensuring the cleanliness of the patient's burn wound and avoiding wound infection, so that the antibacterial agent released by the drug-releasing layer 3 can fully treat the wound and promote wound healing.

[0050] In another optional embodiment of the present invention, the preset value is 1 mg / L.

[0051] In this embodiment, the drug release layer 3 can be a boric acid hydrogel. The detection limit of the boric acid hydrogel for glucose molecules is 1 mg / L. It has a significant response to glucose molecules under the condition of pH = 6.0-7.5, so that the glucose molecules and the boric acid hydrogel can fully interact with each other, causing the drug release layer 3 to swell and release the antibacterial agent, which is then slowly delivered to the wound surface through the drug delivery layer 4 to promote wound healing.

[0052] like Figure 2 As shown, the wound exudate is drained to the drug release layer 3 through the drug delivery layer 4, so that the drug release layer 3 reacts with the glucose molecules in the wound exudate and swells, so that the antibacterial agent in the drug release layer 3 is slowly released from the hydrogel matrix of the drug release layer 3 to the outside of the matrix in the direction A shown by the arrow, and is slowly delivered to the wound through the drug delivery layer 4, thereby promoting wound healing. It should be noted that Figure 2 The black filled circles in the figure represent antimicrobial agents.

[0053] It is worth noting that the larger the wound area is, the more glucose molecules are in the exudate or blood, the faster the swelling rate of the drug release layer 3 is, and the faster the release rate of the antibacterial agent is. Since the drug delivery layer 4 has a pore size of 0.04 to 0.1 mm, the antibacterial agent can be slowly delivered to the wound, thereby preventing and treating wound infection.

[0054] The method for using the burn dressing of the present invention comprises:

[0055] Routine debridement: open the inner packaging bag aseptically, take out the burn dressing, tear off the peeling layer 5, and place the burn dressing close to the wound surface. Press gently for about 1 minute to make the dressing adhere to the wound surface more firmly. If there is a large amount of exudate on the wound surface, it must be replaced in time, and the wound surface should be cleaned each time it is replaced. The burn dressing has been sterilized to meet the sterility requirements. Secondary contamination should be avoided during use.

[0056] The hemostatic principle of the burn dressing of the present invention includes:

[0057] The drug delivery layer 4 is a chitosan membrane, which has active amino groups and can aggregate red blood cells, concentrate platelets, and achieve hemostasis without relying on conventional coagulation pathways.

[0058] The antibacterial principle of the burn dressing of the present invention includes:

[0059] The active amino groups in the drug delivery layer 4 can combine with negatively charged substances in the bacteria, such as milk proteins and nucleic acids, to affect the normal physiological functions of the cells and cause them to die, or adsorb on the surface of bacterial cells to form a polymer film, causing changes in their permeability and causing cell death;

[0060] The antibacterial agent in the drug-releasing layer 3 is gentamicin sulfate, which is an aminoglycoside antibiotic. It has a broad-spectrum antibiotic effect on Gram-positive bacteria and Gram-negative bacteria by interfering with bacterial protein synthesis. Based on the synergistic antibacterial effect of the chitosan film and the antibacterial agent, the effect of the burn dressing on the prevention and treatment of burn wound infection is significantly improved.

[0061] In the above-mentioned embodiments of the present invention, the burn dressing has a simple and practical structure, can reduce the workload of nursing staff and improve patient satisfaction; the boric acid hydrogel swells when in contact with glucose molecules in the exudate and slowly releases antibacterial agents, which helps to promote wound healing; in addition, the chitosan membrane has healing-promoting, analgesic and hemostatic properties, and based on the synergistic effect of the two, it regulates the inflammatory microenvironment of the burn wound, maintains the balance of wound exudate, reduces wound pain and other pathways to accelerate wound healing.

[0062] The above is a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principles of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A burn dressing, It is characterized in that include: Backing layer (1); an absorbent layer (2) located below the backing layer (1); A drug release layer (3) located below the absorption layer (2), wherein the detection limit of the drug release layer (3) for glucose molecules is a preset value; a drug delivery layer (4) located below the drug release layer (3); as well as a peeling layer (5) located below the drug delivery layer (4); Wherein, the drug release layer (3) is a semi-solid material with a viscosity of 50000-70000 mPa.s; The drug release layer (3) is boric acid hydrogel; The boric acid hydrogel is prepared by free radical polymerization initiated by light, with monomers including 3-acrylamidophenylboronic acid, acrylamide, N,N-methylenebisacrylamide and a photoinitiator. The drug-releasing layer (3) contains an antibacterial agent; The preset value is 1 mg / L; Wherein, the drug delivery layer (4) is a chitosan film; The drug delivery layer (4) is provided with holes with a hole diameter of 0.01 to 0.1 mm; The thickness of the drug delivery layer (4) is 0.04-0.1 mm; The chitosan film is composed of a mixture of chitosan and glycerol and has active amino groups.

2. The burn dressing according to claim 1, It is characterized in that The antibacterial agent is an aminoglycoside antibiotic.

3. The burn dressing according to claim 1, It is characterized in that The absorption layer (2) is sponge, non-woven fabric or medical gauze.